ANI Pharmaceuticals | ANIP - Ordinary Share Capital


ANI Pharmaceuticals reported $22.49M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
ANI Pharmaceuticals USD 22.49M 760K Dec/2025
Aurora Cannabis CAD 58.95M 2.24M Mar/2026
Canopy Growth CAD 422.07M 53.78M Mar/2026
Eli Lilly USD 943.5M 3.33M Mar/2026
Emergent BioSolutions USD 100K 0 Jun/2023
Heron Therapeutics USD 188.31M 4.99M Dec/2025
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
Nektar Therapeutics USD 29.47M 9.09M Mar/2026
Novartis USD 1.91B 60K Mar/2026
Omeros USD 611K 17K Dec/2023
Perrigo USD 138.1M 500K Mar/2026
Sun Pharmaceuticals INR 2.4B 0 Mar/2026
Teva Pharmaceutical Industries USD 1.16B 1000K Jun/2026